None listed
Conditions
Interventions
None listed
Sponsors
Pusan National University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Selection Criteria - Adult patients aged 19 or older - Patients diagnosed with solid tumors who are currently eligible for calculation exceptions. - Patients with an Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower (ambulatory and capable of all self-care but unable to carry out any work activities; up and about more than 50% of waking hours). - Patients who newly receive KM–WM collaborative treatment at an outpatient clinic at institutions participating in the pilot project on collaborative treatment between Western and Korean medicine for the management of the following symptoms: = Symptoms related to the diagnosed cancer or cancer-related sequelae = Symptoms occurring during cancer treatment - Patients who have not received KM–WM collaborative treatment for the same symptoms within the past 3 months
Exclusion criteria
Exclusion criteria: ? Patients expected to be difficult to follow up, due to unstable housing, unclear contact information, etc. ? Patients who may have difficulty understanding and responding to the study questionnaire due to illiteracy, mental incapacity, etc. ? Patients seeking treatment for symptoms unrelated to diagnosed cancer, its sequelae, or cancer treatment ? Other patients whom the researcher deems unsuitable for study participation ? Participants in the pilot project for insurance coverage of herbal medicine decoctions† † Not eligible for the Korean medicine and Western medicine collaboration Pilot Project not eligible for concurrent participation in the 5th phase of the Korean Medicine–Western Medicine Collaboration pilot project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Edmonton Symptom Assessement;Numeric Rating Scale(NRS);Recovery status;EuroQol-5 Dimention;EuroQol-Visual Analogue Scale;Cost per QALYs(Quality Adjusted Life Years);Incremental Cost-Effectiveness Ratio;Incremental Net Benefit;Cost-Effectiveness Acceptability Curve | — |
Secondary
| Measure | Time frame |
|---|---|
| Care pathway and cost data survey | — |
Countries
Korea, Republic of
Contacts
Public ContactLinae Kim
Pusan National University
Outcome results
None listed